When Balance Becomes Overstimulation: How THC Hijacks the Brain

The brain has its own cannabis system, and long before humans cultivated marijuana, our neurons were already communicating using cannabis-like molecules called endocannabinoids.

These molecules help regulate mood, memory, appetite, pain, and synaptic plasticity.  They act as a kind of neural “volume control”, fine-tuning communication between neurons. This internal system, called the endocannabinoid system (ECS), is essential for maintaining balance in the brain.[1] Under normal conditions, it works beautifully. But what happens when that carefully balanced system is repeatedly overstimulated by external THC? This question sits at the center of current cannabinoid research.

CB1 Receptors and Neural Signaling

In their review, Kendal & Yudowski (2017) describe how CB1 receptors – the primary receptors activated by THC – are among the most abundant G-protein-coupled receptors (GPCRs) in the brain.[1] These receptors are densely expressed in the hippocampus, prefrontal cortex, basal ganglia, and cerebellum – regions responsible for memory, executive function, reward, and movement.

Under normal conditions, endocannabinoids are produced on demand. They briefly suppress neurotransmitter release to fine-tune synaptic signaling. THC, however, is not produced on demand. It persistently activates CB1 receptors.

Figure 1 (left): Mechanism of retrograde endocannabinoid (eCB) signaling via CB1 receptors in a neural synapse [1]

Kendall & Yudowski explain that repeated THC exposure leads to CB1 receptor desensitization – meaning the receptors become less responsive over time.[1] This contributes to tolerance. The brain adapts by reducing signaling efficiency, shifting intracellular signaling pathways, and altering neural communication. In other words, the brain compensates.

How THC Changes Brain Function

In the short-term, THC exposure is associated with a plethora of cognitive changes, including impaired short-term memory, reduced attention, slower reaction times, altered motor coordination, as well as anxiety. These effects are largely explained by CB1 receptor activation in the hippocampus and prefrontal cortex. For most users, these impairments are temporary, but intoxication can increase risky behavior like impaired driving.[2]

On the other hand, chronic overstimulation of CB1 receptors with repeated or early exposure can produce tolerance, increase the risk of heart disease or stroke, alter reward circuitry, and disrupt executive function.[3]

Adolescent exposure may be particularly concerning. The ECS plays a role in synaptic pruning and cortical maturation during development. Introducing THC during this window may interfere with normal circuit refinement.

Figure 2: The progression of prefrontal cortical maturation and synaptic refinement during adolescence. [4]

Epidemiological studies have linked heavy adolescent cannabis use to increased risk of cognitive impairment and psychiatric vulnerability. [5]

What This Means for Us

While cannabis legalization is expanding, the perception of harm is decreasing, and THC potency has increased dramatically over the past few decades. We now know that the ECS system is not just another neurotransmitter pathway – it is a central regulator of synaptic balance. Repeated exogenous stimulation, however, may shift that system away from homeostasis. So understanding how THC interacts with CB1 receptors is not about morals; it is about informed decision-making. Science does not suggest that all cannabis use leads to irreversible harm. It does suggest that timing, frequency, dose, and developmental stage matter. The ECS system evolved to maintain balance, but the real question remains, “What happens when balance becomes overstimulation?”

References

[1]

D. A. Kendall and G. A. Yudowski, “Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease,” Front. Cell. Neurosci., vol. 10, Jan. 2017, doi: 10.3389/fncel.2016.00294.

[2]

“Marijuana,” Cleveland Clinic. Accessed: Feb. 24, 2026. [Online]. Available: https://my.clevelandclinic.org/health/articles/4392-marijuana-cannabis

[3]

N. D. Volkow, R. D. Baler, W. M. Compton, and S. R. B. Weiss, “Adverse Health Effects of Marijuana Use,” N Engl J Med, vol. 370, no. 23, pp. 2219–2227, Jun. 2014, doi: 10.1056/NEJMra1402309.

[4]

B. C. Meyer Heidi, “Brain Science Has Discovered New Drug-Free Approaches for the Anxious Adolescent,” Scientific American. Accessed: Feb. 24, 2026. [Online]. Available: https://www.scientificamerican.com/article/adolescent-anxiety-is-hard-to-treat-new-drug-free-approaches-may-help/

[5]

M. Arain et al., “Maturation of the adolescent brain,” Neuropsychiatr Dis Treat, vol. 9, pp. 449–461, 2013, doi: 10.2147/NDT.S39776.

From Hemp to Health: A Closer Look at CBD

CBD and the Endocannabinoid System: 

Cannabidiol (CBD) has quickly become one of the most talked-about compounds derived from the cannabis plant. In the brain, CBD acts as an agonist in the endocannabinoid system (ECS). Although its mechanisms are not fully understood, CBD can interact with the two major cannabinoid receptors: CB1 and CB2.  CB1 receptors are largely localized in the brain and play a key role in the modulation of synaptic plasticity and homeostatic processes in the brain. When this signaling goes wrong, it may contribute to various CNS disorders such as Huntington’s Disease and Alzheimer’s Disease. Because of this, the ECS is becoming a source of interest as a new therapeutic target for such neurodegenerative diseases.[1]

To read more, you can find the article here: Frontiers | Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease

One promising source of treatment involving this system is CBD. As mentioned above, it has become increasingly popular as research continues to highlight its immense benefits.

Overview:

CBD is typically derived from the hemp cannabis plant, which contains less than 0.3% THC. Because of this low THC concentration, hemp-derived CBD products do not have psychoactive properties. This allows individuals to use it without experiencing a “high”.

Although researchers do not fully understand how CBD works, research suggests it can slow brain signaling and lower neuroinflammation. Neuroinflammation is involved in many neurological conditions, making CBD’s anti-inflammatory effects an important therapeutic use. Additionally, CBD helps modulate calcium levels in the brain. Since calcium plays a critical role in neurotransmitter release and cell survival, stabilizing calcium levels may help protect neurons from damage.[2]

Potential Benefits:

Based on limited but growing research, CBD has been associated with several potential health benefits:

  • Anxiety reduction
  • Reduced inflammation
  • Nerve-related pain relief [3]
  • Arthritis symptom management
  • Seizure disorders [4]

It is important to note that while these benefits are promising, more research is needed to confirm effectiveness and safety, especially regarding long-term use and side effects.

Risks and Side Effects:

Along with its benefits, the minimal research we have also highlights several mild side effects associated with CBD use:

  • Dry mouth
  • Diarrhea
  • Decreased appetite
  • Drowsiness
  • Fatigue

Several factors can influence the likelihood of adverse effects. These include the product’s strength and purity, the amount used, the method of consumption, and possible drug–drug interactions.[5]

Methods of Use:

CBD can be administered in several ways:

  • Topical skin application – often used for muscle and joint pain
  • Sublingual absorption – typically oils placed under the tongue
  • Oral consumption – most common method involving pills and edibles
  • Smoking or vapor inhalation – allows rapid, direct absorption, but is associated with more severe and long-term side effects [6]

Final Thoughts:

CBD is a promising compound with anti-inflammatory and neuroprotective potential, but it is not a cure-all, and the absence of long-standing research must be acknowledged. Even so, it is a beneficial example of how using the ECS as a therapeutic target can reach millions of people with all types of disorders.

[1] Debra A. Kendall and Guillermo A. Yudowski, “Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease,” Frontiers in Cellular Neuroscience 10 (January 2017), https://doi.org/10.3389/fncel.2016.00294.

[2] “CBD vs. THC: What’s the Difference?,” WebMD, accessed February 17, 2026, https://www.webmd.com/pain-management/cbd-thc-difference.

[3] WebMD, “CBD vs. THC.”

[4] “What Is Cannabidiol (CBD)? Uses, Benefits, and More,” Healthline, August 3, 2018, https://www.healthline.com/health/your-cbd-guide.

[5] Healthline, “What Is Cannabidiol (CBD)?”

[6] Healthline, “What Is Cannabidiol (CBD)?”

Rethinking Alzheimer’s: What the Future of Treatment Might Look Like

Alzheimer’s is a brain disorder that slowly damages memory and thinking. An affected brain has Amyloid-beta plaques that build up between brain cells as well as Tau tangles inside the cells.

These changes in the brain disrupt communication between neurons and can ultimately lead to their death, contributing to memory loss. [1]

According to the Alzheimer’s association, over 7 million Americans are living with Alzheimer’s disease with that number being expected to rise to 13 million in the next 25 years. [2]

 

This picture was sourced from Alzheimers Research UK

For more information about Alzheimer’s affects click here

Treatments of Alzheimer’s Disease in the past:

Aduhelm, a drug that was approved for a short time in 2021, showed that removing the beta-amyloid plaques was able to reduce cognitive decline. [3] It was the only new drug that was approved for the treatment of Alzheimer’s since 2003. [4]

Most approved drugs target symptoms not stopping disease progression. Stopping the disease progression is the huge hurdle in Alzheimer’s research. This is mostly due to late initiation of treatments and incorrect targets for treatment. Additionally, there is a wide gap in knowledge of the complexities involved in the pathophysiology of this disease. [4].

Scientists can’t just fix a single spot. They would have to rebalance an entire network of cellular communication. Inside brain cells are protective signaling systems, including pathways known as PI3K and Akt. These pathways help cells survive, repair damage, and regulate important processes. When they stop working properly, the neurons become more vulnerable thus contributing to plaque buildup and eventually cell death. Trying to adjust these pathways without disrupting other functions is extremely complex. [5] Additionally, the complexities of this disease would require a combination of treatments [4].

But what if Alzheimer’s isn’t just about plaques- but about how brain cells process energy?

What the future may hold:

The future of Alzheimer’s treatment may not rely on removing plaques in the brain. Instead, the focus may be on the restoration of the insulin pathways.

Is Alzheimer’s Type 3 Diabetes?

Brain cells need glucose to function, and insulin helps the cells in our brains use that energy. In a brain affected by Alzheimer’s, the cells become Insulin resistant like in type two diabetes. Because of this, some scientists have begun referring to Alzheimer’s as Type 3 diabetes.

 

This inability to properly use glucose causes a struggle for cells to produce the energy needed to communicate. This energy failure is what can cause the PI3K and Akt pathways to stop functioning properly. [5]

 

This image was sourced from News Medical & Life Sciences

This shift in understanding has opened new possibilities for treatment. Now, researchers are exploring therapies that improve insulin signaling and restore the brains’ ability to use energy effectively.

One medication that researchers are exploring is Metformin, a drug commonly prescribed for type 2 diabetes. Metformin improves the body’s sensitivity to insulin and is being investigated to support the brains’ ability to use glucose efficiently. [6]

Alzheimer’s disease research has long been focused on amyloid plaques and tau tangles, and many treatments have been focused on removing these proteins. But targeting plaques alone has not been enough to stop the progression of the disease suggesting deeper disruptions, such as impaired insulin signaling, are also involved. Therefore, the future of Alzheimer’s treatment may depend on restoring the brains energy balance, protecting pathways like PI3k and Akt and combining multiple therapies rather than relying on a single target.

  1. Alzheimer’s disease fact sheet. (2023, April 5). National Institute on Aging. https://www.nia.nih.gov/health/alzheimers-and-dementia/alzheimers-disease-fact-sheet
  2. Alzheimer’s disease facts and figures. (n.d.). Alzheimer’s Association. Retrieved February 18, 2026, from https://www.alz.org/alzheimers-dementia/facts-figures
  3. Aducanumab to be discontinued as alzheimer’s treatment | alz. Org. (n.d.). Alzheimer’s Association. Retrieved February 18, 2026, from https://www.alz.org/alzheimers-dementia/treatments/aducanumab
  4. Yiannopoulou, K. G., Anastasiou, A. I., Zachariou, V., & Pelidou, S.-H. (2019). Reasons for failed trials of disease-modifying treatments for alzheimer disease and their contribution in recent research. Biomedicines, 7(4), 97. https://doi.org/10.3390/biomedicines7040097
  5. Akhtar, A., & Sah, S. P. (2020). Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer’s disease. Neurochemistry International, 135, 104707. https://doi.org/10.1016/j.neuint.2020.104707
  6. Daly, T., & Imbimbo, B. P. (2025). Long‐term metformin use for Alzheimer’s disease prevention? Alzheimer’s & Dementia, 21(4), e70147. https://doi.org/10.1002/alz.70147
    ChatGPT was used in the formation of this post

Alzheimer’s Disease: Understanding the Stages and How Your Diet Can Make a Difference

Alzheimer’s Disease: Understanding the Stages and How Your Diet Can Make a Difference

Most people have some knowledge of Alzheimer’s Disease (AD). Whether it be a relative who suffers its effects, or through vivid depictions in media, AD is one of the most prevalent examples of a neurodegenerative disease. Its prevalence, however, masks some important aspects of its progression, as most people only become aware of it in its later stages. People, therefore, are aware of its position as a malady that afflicts many in their old age, but don’t have a solid understanding of how the disease progresses, or what we can do to reduce the risk.

The Three Stages of AD

AD begins quietly. The first stage is characterized by the gradual accumulation of beta-amyloid plaques. At this point, AD is still early in its progression, and lacks the distinctive calling cards of late stage AD. Those unfortunate enough to be in the first stage usually wouldn’t know about it, as the first stage can last from 10-20+ years before progression onto the second stage.1 Compared to people in further stages, people in the first stage still function fine, as neurodegeneration hasn’t begun to kick in. If caught, this is the ideal stage to treat Alzheimer’s, as the beta-amyloid accumulation is early enough to treat; however, many don’t, as the requisite blood tests are not commonplace in our day-to-day routine.

Stage two is where neurodegeneration begins. Brain cells start to deteriorate and cognitive changes emerge, though most people can still manage day-to-day life. This is when many people receive their diagnosis, and hence the stage where most pharmaceuticals are targeted – the aim being to prevent accumulation before even more damage to the brain. By the third stage, patients are in the worst of the neurodegeneration. Suffering permanent damage to the brain, treatments look at repairing damaged connections in the brain, as beta-amyloid accumulation is too far gone to prevent. Patients usually lose most of their grip with reality and are relegated to assisted living communities for constant care.

The Insulin Connection

To understand how diet plays a role, it helps to know what’s going wrong at the cellular level. Alzheimer’s is defined by two features: neurofibrillary tangles (NFTs) formed through abnormal changes in a protein called tau, and the beta-amyloid plaques described above. Both are tied to insulin. When you eat, your body releases insulin to help cells use energy from food. Two enzymes – GSK-3B and PI3K – are central to how insulin affects the brain. When insulin signaling works properly, GSK-3B is kept in check, which limits tau changes and plaque deposition. When it doesn’t, GSK-3B becomes overactive and accelerates the processes that define AD.2 Healthy signaling protects the brain; disrupted signaling does the opposite. 

How Diet Fits In: What You Can Do

Diets high in sugar and unhealthy fats increase insulin resistance, making it harder for insulin to do its job. It’s worth noting that roughly 80% of Alzheimer’s patients also have dysfunctional glucose regulation, including type 2 diabetes, which is not likely a coincidence.3 High-fat diets also promote chronic neuroinflammation, further accelerating plaque accumulation and NFT formation. While a healthy diet won’t make you immune to AD, the link between diet, insulin, and brain health is real, and it’s something you can act on without overhauling your life.4 Being more mindful of sugar and calorie intake, and gradually reducing ultra-processed foods, is a meaningful step. Small, consistent choices add up, and when it comes to brain health, they may matter more than we once thought.

 

(1) Staff, M. C. Alzheimer’s stages: How the disease progresses. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers-stages/art-20048448 (accessed 2026-02-17). 

(2) Akhtar, A.; Sah, S. P. Insulin Signaling Pathway and Related Molecules: Role in Neurodegeneration and Alzheimer’s Disease. Neurochem. Int. 2020, 135, 104707. https://doi.org/10.1016/j.neuint.2020.104707. 

(3) Janson; Laedtke; Parisi; O’Brien; Et., A. Increased Risk of Type 2 Diabetes in Alzheimer Disease. Diabetes 2004. https://doi.org/10.2337/diabetes.53.2.474. 

(4) What Do We Know About Diet and Prevention of Alzheimer’s Disease? National Institute on Aging. https://www.nia.nih.gov/health/alzheimers-and-dementia/what-do-we-know-about-diet-and-prevention-alzheimers-disease (accessed 2026-02-17). 

Can’t remember what you had for lunch? Your diet can possibly influence your risk for Alzheimer’s.

Why should I care about this?

When you eat, your body needs a hormone called insulin in order for your body to utilize the energy in the food. Recent evidence suggests that insulin plays a very important role in the mechanisms behind Alzheimer’s and other neurodegenerative diseases. Often, the foods that taste so good to us, such as ultra-processed foods with large amounts of sugar and unhealthy fats, are not so great for insulin pathways. Therefore, if something that we can control like our diet can influence our risk for a disease as terrible as Alzheimer’s, we should do what we can to avoid developing it.

How insulin can affect Alzheimer’s

Alzheimer’s is characterized by two things, the first thing being NFTs that are formed through abnormal phosphorylation of a protein called tau, and the formation of something called Amyloid-beta plaques which will be referred to as AB plaques from this point forward (1). For a more detailed explanation of the ins and outs of Alzheimer’s, check out this article. Insulin pathways are what we call the chain of events that occur after the introduction or removal of insulin. Some components of these pathways can contribute to the formation of NFTs and AB plaques. One of these components involves an enzyme called GSK-3B, which is essential for metabolism of glucose but it also plays a role in tau phosphorylation. When insulin is not bound to a receptor, GSK-3B is activated, and when GSK-3B is activated, it promotes tau phosphorylation and deposition of AB plaques (2). Therefore, we want insulin to bind and deactivate GSK-3B in order to help prevent the formation and accumulation of NFTs and AB plaques. Another component worth talking about is another enzyme called PI3K. When PI3K is active, it inhibits GSK-3B. When PI3K is not functioning properly, it can lead to overactivation of GSK-3B, causing an excess of tau phosphorylation and AB plaque deposition (2). This is another reason why we want our insulin pathways to be working properly.

How does your diet affect insulin signaling?

Insulin binds to receptors that start the chain reactions of insulin pathways and without them, insulin would simply float there and do nothing. Insulin resistance refers to the ease at which insulin can bind to these receptors, meaning a higher insulin resistance makes it more difficult for insulin to bind properly. Type 2 diabetes is the development of high resistance to insulin, a disease that is characterized by unhealthy diets in those who develop it.

Interestingly, 80% of Alzheimer’s patients also have type 2 diabetes. When we eat an excess amount of calories, our cells adjust the amount of receptors in order to avoid overactivation of insulin pathways caused by the high levels of insulin released. Highly processed foods are characterized by high levels of sugar and unhealthy fats which are extremely calorically potent and therefore they increase insulin resistance (3). By increasing insulin resistance, we make it more difficult for insulin to do its job, which consequently results in less activation of PI3K and therefore less deactivation of GSK-3B. Additionally, diets that are high in fat can result in chronic neuroinflammation, which also contributes to AB plaque accumulation and NFT formation (4).

What should you do now?

You don’t need to necessarily follow a strict diet to prevent Alzheimer’s, nor will following one make you immune to Alzheimer’s. AB plaque accumulation and NFT formation are heavily influenced by insulin signaling, but they are also influenced by other things as well. Chances are, other consequences of an unhealthy diet are more likely to kill a person much before they start to develop Alzheimer’s, such as high blood pressure, diabetes, heart failure and a higher risk of cancer. If anything, these should be a much more compelling reason to change your diet. Being more aware of what you are eating, like how much sugar is in something and how many calories, can go a long way in changing eating habits. Changing your diet doesn’t mean following a well-known diet or only eating healthy foods, it can simply involve reducing the amount of unhealthy things you eat. As with everything in life, moderation is key. So maybe next time you get some candy, get the normal sized package instead of the share size. Or before you upgrade your meal at McDonald’s to a large, think about if paying an extra thirty cents for more food is really needed or if you simply want to do it because it is a better deal.

 

  1. Breijyeh, Z., & Karaman, R. (2020). Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules (Basel, Switzerland)25(24), 5789. https://doi.org/10.3390/molecules25245789
  2. Akhtar, A., & Sah, S. P. (2020). Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer’s disease. Neurochemistry international135, 104707. https://doi.org/10.1016/j.neuint.2020.104707
  3. Ede, G. (2016). Avoiding Alzheimer’s Disease Could Be Easier Than You Think. Psychology Today. https://www.psychologytoday.com/us/blog/diagnosis-diet/201609/avoiding-alzheimer-s-disease-could-be-easier-you-think\
  4. Song, M., Bai, Y., & Song, F. (2025). High-fat diet and neuroinflammation: The role of mitochondria. Pharmacological research212, 107615. https://doi.org/10.1016/j.phrs.2025.107615

When Tau Twists: Understanding Neurofibrillary Tangles in Alzheimer’s Disease

Alzheimer’s Disease and Neurofibrillary Tangles:

One of the most common neurodegenerative diseases, Alzheimer’s Disease (AD), is a form of dementia characterized by two hallmarks: amyloid-β plaques and neurofibrillary tangles (NFTs). An important discovery has been made linking insulin resistance to the formation of these hallmarks. The activation or inactivation of key molecules in the insulin signaling pathway, such as PI3K, Akt, GSK-3β, and mTOR, can either increase or decrease phosphorylation. Modulation in phosphorylation creates insulin signaling deficiencies, leading to what is known as “brain insulin resistance”. When insulin signaling in the brain is dysfunctional, AD symptoms are accelerated, and the formation of amyloid-β plaques and NFTs is promoted.[1] To read more about the connection between “brain insulin resistance” and Alzheimer’s Disease click here.

Understanding these AD hallmarks is essential for better diagnosis and treatment techniques. In this post, we will explore the formation, structure, and importance of neurofibrillary tangles.

The Formation and Structure of NFTs:

To begin, it is important to note that tau proteins play an essential role in stabilizing microtubules in the brain. The formation of NFTs begins when hyperphosphorylated tau proteins detach from these microtubules. Without the adherence to microtubules, tau proteins misfold and twist into paired helical filaments, which then accumulate inside the neuronal cell body. These paired helical filaments eventually condense into the large, dense masses known as NFTs.[2] This process is further outlined in the image below.[3]

The Spreading of NFTs:

A significant aspect of NFTs is how they spread throughout the brain. They use a prion-like mechanism, in which misfolded tau proteins induce the surrounding functional tau proteins to adopt their misshapen conformation. Along with this rapid spreading mechanism, NFTs remain even after the host neuron dies. These tangles remain behind as extracellular remnants, contributing to ongoing neurodegeneration.[4]

The Maturity Levels of NFTs:

NFTs develop through three progressive stages:

  1. Pretangles
  • Diffuse cytoplasmic tau staining
  • Perinuclear tau accumulation (surrounding the nucleus)

This is the earliest stage, where tau buildup begins, but dense bundles have not yet formed.

  1. Mature Tangles
  • Densely packed bundles
  • Nuclear shrinking

At this stage, the tangles have fully formed, disrupting cellular function.

  1. Ghost Tangles
  • Extracellular remnants
  • Loosely arranged bundles without a nucleus

These remain after the host neuron has died and act as a lasting marker of damage outside of the cell. [5]

Why NFTs Matter:

Understanding NFTs is critical because they represent both a mechanism of cell degradation and a measure of disease progression. By targeting tau misfolding, aggregation, or spread, researchers hope to slow or halt neurodegeneration, serving as a promising therapeutic target for Alzheimer’s Disease.

[1] Ansab Akhtar and Sangeeta Pilkhwal Sah, “Insulin Signaling Pathway and Related Molecules: Role in Neurodegeneration and Alzheimer’s Disease,” Neurochemistry International 135 (May 2020): 104707, https://doi.org/10.1016/j.neuint.2020.104707.

[2] “What Are Neurofibrillary Tangles and How Do They Form?,” ScienceInsights, November 27, 2025, https://scienceinsights.org/what-are-neurofibrillary-tangles-and-how-do-they-form/.

[3] “Hyperphosphorylation of Tau Protein. Hyperphosphorylation of the Tau…,” ResearchGate, accessed February 10, 2026, https://www.researchgate.net/figure/Hyperphosphorylation-of-tau-protein-Hyperphosphorylation-of-the-tau-protein-causes-the_fig1_376735971.

[4] ScienceInsights, “What Are Neurofibrillary Tangles and How Do They Form?”

[5] Christina M. Moloney et al., “The Neurofibrillary Tangle Maturity Scale: A Novel Framework for Tangle Pathology Evaluation in Alzheimer’s Disease,” bioRxiv, June 6, 2025, 2025.06.02.657435, https://doi.org/10.1101/2025.06.02.657435.

BDNF and Alzheimer’s: Can Growth Factors Boost the Brains Repair System?

The Story of BDNF and Alzheimer’s

The human brain is constantly adapting to experience. Everyday it builds new connections, repairs damage, and keeps signaling steady. When the brain’s systems start failing, signals slow and memory fades. This is what happens as Alzheimer’s disease develops. An important protein in this process is called brain derived neurotropic factor, or BDNF. This is a growth factor in the central nervous system that supports neuron growth, survival, signaling, and promotes synaptic plasticity, which we need for learning, memory, and emotional regulation [1]. BDNF acts by binding to a receptor on neurons, called TRKB, triggering various signaling pathways that promote cell survival and functional signaling [2]. High BDNF levels are healthy and strengthen the brain, whereas low BDNF levels lead to weak neurons and foggy memory.

This image shows which pathways are activated by BDNF binding and the various effects it supports in the brain [5].

Growth Factors

Growth factors, in general, have a significant role in brain health. They support many brain mechanisms, such as insulin signaling in the brain. Many people are aware of insulin’s role in relation to blood sugar, but it is also incredibly important to the brain. Abnormal insulin signaling in the brain can lead to poor glucose metabolism (how the brain gets energy), neuron death, and Alzheimer’s disease. This means that the brain loses energy and its repair mechanisms, resulting in amyloid-B accumulation, inflammation, and synaptic loss. Insulin signaling pathways overlap with growth factor signaling pathways, like those activated by BDNF. Growth factors counter these effects of poor insulin signaling, by reducing inflammatory signaling and protecting neurons from amyloid-B toxicity, common in Alzheimer’s disease [3].

Influencing Growth Factors

Growth factors can be influenced by lifestyle and habits. Scientists have found that activities like regular exercise, quality sleep, social interaction, cognitive engagement, and diets rich in omega-3 fats and antioxidant compounds can increase BDNF levels. On the flip side, chronic stress, sleep deprivation, high saturated fats, refined sugars, and depression all correlate with lower BDNF production. Therefore, we can influence the pathways in the brain that support resilience.

This video from integrative natropathologist and pharmacist, Vanita Dahia, further explains the connection between BDNF and Alzheimer’s, and some methods to promote BDNF levels.

Brain Repair?

But what about people who are already experiencing neurodegeneration, where lifestyle changes might not be enough to restore lost neuron connections? Researchers are investigating therapeutic strategies to boost growth factor signaling in the brain. One promising approach is gene therapy. Vectors carry genes that code for growth factors directly into brain tissue. These genes will produce growth factors long-term within neurons [4]. Early clinical trials suggest this approach can promote neuron survival and slow Alzheimer’s disease progression. Another strategy uses intranasal sprays, delivering growth factors from the nose directly into the brain. This path avoids the bloodstream, which reduces side effects [7]. Both approaches remain experimental and no growth factor therapy has been approved as treatment for Alzheimer’s, though these methods are hopeful.

This image describes the process of BDNF gene therapy, and how it can be used to repair the brain in those with Alzheimer’s disease [6].

Conclusion

Therefore, the story of BDNF and Alzheimer’s teaches us that brain health includes a complex signaling networks that include insulin, growth factors, and cellular energy systems. It also shows us that the brain’s vulnerability to disease uses the same systems that support its resilience. The brain responds to signals from growth factors, like BDNF, which are influenced by lifestyle choices. Advanced therapies offer hope for repairing damage at the cellular level, but everyday habits are important too. With each discovery about insulin, BDNF, and neurodegeneration, we gain a clearer picture of how to protect the brain and growth factor therapies may be able to repair the brain.

A concise summary can be viewed at http://neurochemistry2026.pbworks.com/w/page/163250862/BDNF%20and%20GFs%20as%20AD%20therapy .

 

References

[1] Bathina, Siresha & Das, Undurti. 2015. Brain-derived neurotrophic factor and its clinical Implications. Archives of medical science : AMS. 11. 1164-1178. 10.5114/aoms.2015.56342.

[2] Colucci-D’Amato, L., Speranza, L., & Volpicelli, F. 2020. Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. International journal of molecular sciences21(20), 7777. https://doi.org/10.3390/ijms21207777

[3] Akhtar, A., & Sah, S. P. 2020. Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer’s disease. Neurochemistry International135, 104707. https://doi.org/10.1016/j.neuint.2020.104707

[4] Tuszynski M. H. 2024. Growth Factor Gene Therapy for Alzheimer’s Disease. Journal of Alzheimer’s disease : JAD101(s1), S433–S441. https://doi.org/10.3233/JAD-240545

[5] Numakawa, T., & Kajihara, R. 2023. Involvement of brain-derived neurotrophic factor signaling in the pathogenesis of stress-related brain diseases. Frontiers. https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2023.1247422/full

[6] BDNF. ACROBiosystems. https://www.acrobiosystems.com/category/target-protein/bdnf?msclkid=04fd2c7c9c4e13fc84bc45efc20fee07&utm_source=bing&utm_medium=cpc&utm_campaign=PL.-CYTOK%2BTARGETS.-%5BUSA%5D.-DSA-Bing&utm_term=https%3A%2F%2Fwww.acrobiosystems.com%2Fcategory%2Ftarget-protein%2Fbdnf&utm_content=CYTOK%2BTARGETS.-CUSTOM

[7] Cattaneo, A., Capsoni, S., & Paoletti, F. 2008. Towards non invasive nerve growth factor therapies for Alzheimer’s disease. Journal of Alzheimer’s disease : JAD15(2), 255–283. https://doi.org/10.3233/jad-2008-15210

Beyond Symptoms: Molecular Recovery After a Concussion

[1]

A concussion, a form of mild traumatic brain injury (mTBI), occurs when biomechanical force is applied to the brain and produces functional disturbances without obvious structural damage on standard imaging. These disturbances can generate symptoms such as headaches, dizziness, nausea, photophobia, and slowed cognitive processing. Because concussions frequently occur in athletic participation and military service, understanding their biological impact extends beyond the clinic and into everyday decision-making.

For readers seeking a foundational overview of concussion mechanisms and symptoms, concussion overview resources can provide helpful context.

Despite advances in research, uncertainty remains regarding what full recovery truly means. Observable symptoms may resolve within days, yet metabolic and cellular processes may continue beneath the surface. This neurometabolic complexity challenges symptom-based recovery assessment and raises concerns about when individuals should safely resume high-risk activities. Biomarker research, including studies of N-acetylaspartate (NAA), whose levels decrease following injury and gradually normalize during recovery, suggests that biological healing may lag behind symptom resolution.[2]

Therefore, examining concussion through a molecular lens reframes recovery as an ongoing physiological process rather than a purely symptomatic experience. A brief visual explanation of symptom progression versus biological recovery can be explored in this short educational video.

Inside the brain’s emergency response

The article by Giza and Hovda describes concussion as triggering a neurometabolic cascade characterized by ionic flux, excessive glutamate release, and increased energy demand.[2] Immediately following injury, potassium exits neurons while calcium enters, disrupting cellular equilibrium. Excessive glutamate release amplifies neuronal activation, forcing cells to expend ATP to restore balance. This mismatch between energy supply and demand creates a temporary metabolic crisis associated with slowed cognition and impaired reaction time.

Mitochondrial strain and altered neurotransmission may persist even in the absence of widespread neuronal death. Spectroscopy studies reporting reduced NAA levels further support the idea that neuronal metabolic function may recover more slowly than symptoms resolve.[2] These findings reinforce that a concussion is not merely a mechanical event, but a dynamic biochemical process unfolding over time.

Figure 1: Neurometabolic cascade following concussion[2]

Why the science matters beyond the Lab

Understanding these mechanisms informs both prevention and recovery strategies. Efforts aimed at reducing concussion incidence increasingly emphasize behavioral adjustments and protective practices, as discussed in concussion prevention in sports.

Recognizing that biological healing may extend beyond symptom relief also helps contextualize why some individuals experience lingering cognitive effects, a phenomenon explored in discussions of post-concussion recovery variability.

At a broader societal level, awareness of cumulative neurological risks has reshaped conversations surrounding athlete safety and military health. Conditions such as chronic traumatic encephalopathy are described in clinical overviews of CTE, reinforcing the importance of long-term monitoring and informed policy decisions.

Figure 2(right): Illustration of the nonlinear nature of concussion recovery, showing that progress may fluctuate and reinforcing the importance of considering biological healing beyond symptom resolution.[3]

Moving forward

Exploring concussion through molecular neuroscience reinforces that recovery is more than the absence of symptoms; it is a biological process unfolding at the cellular level. Recognizing this complexity invites continued curiosity about emerging biomarkers and recovery assessment tools. Ultimately, understanding the hidden physiology of concussion empowers individuals and communities to approach brain health with greater caution, awareness, and scientific engagement.

Bibliography

[1] asc-ca, “What is a Concussion?,” Ace Sports Clinic. Accessed: Feb. 10, 2026. [Online]. Available: https://www.acesportsclinic.com.au/blog/what-is-a-concussion/

[2] C. C. Giza and D. A. Hovda, “The new neurometabolic cascade of concussion,” Neurosurgery, vol. 75 Suppl 4, no. 0 4, pp. S24-33, Oct. 2014, doi: 10.1227/NEU.0000000000000505.

[3]  “Midwest Concussion Clinic – Matt Campbell on Instagram: ‘The 5 Stages of Concussion Recovery is something we discuss with our patients. It’s a way to provide visual representation as to progress in your recovery. The goal is to always move forwards between stages, but sometimes we have setbacks. Setbacks do not mean that you’re “getting worse.” They simply represent a temporary increase in symptoms. Have you ever been educated on the stages of recovery? #Concussion #ConcussionRehab #ConcussionEducation #ConcussionAwareness #ConcussionClinic #ConcussionRecovery #MWConcussion,’” Instagram. Accessed: Feb. 11, 2026. [Online]. Available: https://www.instagram.com/mwconcussion/p/CvYbaU9Aiwb/

We are our Brain’s Protector

Nobody wants to suffer from Alzheimer’s disease, but what is there to do about it but hope it doesn’t happen to you? However, research shows that there are things we can do to delay this disease from impacting us. Alzheimer’s disease (AD) is being called “type 3 diabetes.” Here we will explore why it has been given this name, what is occurring in a brain with AD, and the research on prevention and treatment. [1]

Symptoms of AD

Outwardly, symptoms of AD include difficulties with memory, concentrating, reasoning, thinking, suitable decision making, and planning, as well as changes in personality and behavior. [2]

For more information about how the symptoms of AD present click here

Looking inside the brain

AD is a neurodegenerative disease, meaning neurons and cells in the brain die and brain matter deteriorates. The primary characteristic of AD is neurofibrillary tangles and amyloid-ß plaques. These are basically gunk within and between cells that prevents signals from being able to be sent effectively. It is like when your gutter has leaves clogging it up and blocking water from flowing, but instead of water, brain signals are prevented from continuing to the next cell. Neuroinflammation also plays a large role in AD. [1]

Figure 1: Neurofibrillary tangles and amyloid-ß plaques [3]
Figure 2: Neurodegeneration of the brain in AD [4]
 

 

 

 

 

 

 

Type 3 Diabetes

Patients with type 2 diabetes are at higher risk for developing AD. Research has shown, that like type 2 diabetes, AD is strongly related to insulin resistance (described below). [1]

Insulin

We most commonly hear about insulin in relation to diabetes. When our blood sugar level is elevated, insulin is responsible for helping cells to absorb this glucose, lowering blood sugar levels. [5] Insulin is important in many other functions as well including cell growth, how the cell uses and produces energy, cell communication, and cognition. [1]

Insulin Resistance

Insulin resistance is a dysfunction of insulin signaling. Insulin does not interact with receptors, causing signaling as often and these receptors are less sensitive to the insulin, so, it takes more insulin for the same effects that took less previously to occur. In AD, this occurs in the brain and leads to neurofibrillary tangles, amyloid-ß plaques, neuroinflammation, and neurodegeneration. [1]

Prevention

Figure 3: Gut-brain-axis [6]

Similar to type 2 diabetes, diet, exercise, and lifestyle play a huge role in the development and progression of AD. Our guts and brains are closely connected through multiple pathways in our body, and limiting fat in diet and eating less processed food can decrease your chances of developing AD as well as many other diseases. [1]

Treatment

Due to its similarities to type 2 diabetes, anti-diabetic drugs are a potential treatment for AD, as well as directly administering insulin to the brain. [1] The potential to dissolve/remove the neurofibrillary tangles and amyloid-ß plaques is also being investigated. There are many aspects and systems involved the progression of AD and it effects a large number of individuals, therefore it continues to be a topic of heavy research for treatment and prevention.

 

Footnotes

[1] Akhtar, A., & Sah, S. P. (2020). Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer’s disease. Neurochemistry International, 135, 104707. https://doi.org/10.1016/j.neuint.2020.104707

[2] Alzheimer’s disease—Symptoms and causes. (n.d.). Mayo Clinic. Retrieved February 14, 2026, from https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447

[3] Armstrong, B. (2025, February 24). Understanding Plaques and Tangles in Alzheimer’s Disease. Kinesiology. https://kin.uncg.edu/2025/02/24/plaques-and-tangles/

[4] Alzheimer’s Disease Fact Sheet. (2023, April 5). National Institute on Aging. https://www.nia.nih.gov/health/alzheimers-and-dementia/alzheimers-disease-fact-sheet

[5] Lannon, R. (2024). How Stress Hormones Affect Blood Sugar Levels in Diabetes. African Journal of Diabetes Medicine, 32(5). https://doi.org/10.54931/AJDM-32.5.7

[6] Tan, H.-E. (2023). The microbiota-gut-brain axis in stress and depression. Frontiers in Neuroscience, 17. https://doi.org/10.3389/fnins.2023.1151478

Rest isn’t an optional pause: Concussion Recovery

Rest after a Traumatic Brain Injury is not just about symptom relief. It’s a vital biological process that allows the brain to repair itself. Without rest, the brain remains in a vulnerable state where healing systems cannot function properly. A main factor that influences this vital rest period is age. [1]

The Brains Quiet Recovery

The brains repair process occurs quietly, on an ionic level, making it difficult to completely determine when someone is back to normal. Recovery doesn’t end when symptoms fade. [2] There is a common blanket statement often told that rest is important the first 24-48 hours post brain injury. [3] This recommendation is supported by current concussion management guidelines. A brain cannot operate on a universal recovery timeline and happens differently in every individual. Some neural systems may stabilize quickly, while others remain the same or even decline.[4] This provokes the question of if we can’t see brain recovery, how do we decide when someone is truly healed?

The topic of rest after a mild Traumatic Brain Injury is still being researched because of all the complexities involved. It’s particularly difficult because a TBI occurs invisibly and standard brain scans can look normal even after a severe injury. [5]

Instead, clinicians rely on cognitive and behavioral assessments such as the Glasgow Coma Scale. It is used to assess a person’s level of consciousness after a brain injury. There is also The Rancho Los Amigos (RLA) Cognitive Scale which uses a 10 level assessment to measure recovery. These tools are useful early on but it does not measure subtle cognitive changes that characterize recovery from mild Traumatic Brain Injury.

This image was source from Buddhi Clinic

The Role Age Plays

Recent findings on Brain blood barrier disruptions across all ages and the biology of rest help explain why recovery timelines of recovery vary so widely. After a traumatic brain injury, the brain undergoes a metabolic cascade. This cascade generally follows the same pattern, however the duration and intensity of these disruptions in the brain are unique to each person.[4]

A longitudinal study conducted by Marquez de la Plata CD et al. found that older patients show greater decline in the first 5 years after a TBI while the most improved were the youngest patients. [6]

Limited understanding of TBI recovery can cause people to ignore recommendations to rest while also contributing to under-diagnosis thereby having negative effects including a reduced quality of life and even death. [7] Therefore, it is vital to promote individualized recovery rather than a one-size-fits-all recommendation. Increasing understanding of recovery post TBI can also help to develop age related recovery guidelines. This understanding of recovery affects how people make decisions at school, work and in healthcare.

The most important thing to remember about a traumatic brain injury is that recovery doesn’t end when symptoms fade. After a concussion, the brain is quietly working to restore its protective barriers and reduce inflammation. Returning to school or work too quickly can prolong symptoms or increase vulnerability to re-injury. Rest isn’t an optional pause- it’s the biological window that makes recovery possible.

 

Diagram sourced from Harvest Counseling and Wellness

 

ChatGPT was used in the formation of this post

  1. de la Plata, C. M., Hart, T., Hammond, F. M., Frol, A., Hudak, A., Harper, C. R., O’Neil-Pirozzi, T., Whyte, J., Carlile, M., & Diaz-Arrastia, R. (2008a). Impact of age on long-term recovery from traumatic brain injury. Archives of Physical Medicine and Rehabilitation, 89(5), 896–903. https://doi.org/10.1016/j.apmr.2007.12.030
  2. Wilson, L., Stewart, W., Dams-O’Connor, K., Diaz-Arrastia, R., Horton, L., Menon, D. K., & Polinder, S. (2017). The chronic and evolving neurological consequences of traumatic brain injury. The Lancet. Neurology, 16(10), 813–825. https://doi.org/10.1016/S1474-4422(17)30279-X
  3. Guidelines for recovery. (n.d.). Concussion Alliance. Retrieved February 10, 2026, from https://www.concussionalliance.org/recovery-guide
  4. Giza, C. C., & Hovda, D. A. (2014). The new neurometabolic cascade of concussion. Neurosurgery, 75(Supplement 4), S24–S33. https://doi.org/10.1227/NEU.0000000000000505
  5. Lee, B., & Newberg, A. (2005). Neuroimaging in traumatic brain imaging. NeuroRx, 2(2), 372–383. https://doi.org/10.1602/neurorx.2.2.372
  6. Marquez de la Plata, C. D., Hart, T., Hammond, F. M., Frol, A. B., Hudak, A., Harper, C. R., O’Neil-Pirozzi, T. M., Whyte, J., Carlile, M., & Diaz-Arrastia, R. (2008). Impact of age on long-term recovery from traumatic brain injury. Archives of Physical Medicine and Rehabilitation, 89(5), 896–903. https://doi.org/10.1016/j.apmr.2007.12.030
  7. National Academies of Sciences, E., Division, H. and M., Services, B. on H. C., Policy, B. on H. S., Care, C. on A. P. in T. B. I. R. and, Matney, C., Bowman, K., & Berwick, D. (2022). Traumatic brain injury prevention and awareness. In Traumatic Brain Injury: A Roadmap for Accelerating Progress. National Academies Press (US). https://www.ncbi.nlm.nih.gov/books/NBK580082/

Spam prevention powered by Akismet